Humoral theory of transplantation: further evidence

被引:161
作者
Terasaki, PI [1 ]
Cai, JC [1 ]
机构
[1] Terasaki Fdn Lab, Los Angeles, CA 90064 USA
关键词
D O I
10.1016/j.coi.2005.07.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the two and a half years following our initial paper on the humoral theory of transplantation, many publications have emerged in support of the hypothesis, with no studies in opposition. It is accepted that the role of antibodies is incontrovertible in hyperacute rejection, although what fraction of acute rejection is humoral remains to be determined. A recent large-scale prospective trial showing that transplant patients with antibodies have twice the failure rate as those without antibodies suggests that chronic rejection is also caused by antibodies. Together with serum creatinine, HLA antibodies are, therefore, the best predictor of graft function in kidney patients.
引用
收藏
页码:541 / 545
页数:5
相关论文
共 34 条
[1]   Rituximab as treatment for refractory kidney transplant rejection [J].
Becker, YT ;
Becker, BN ;
Pirsch, JD ;
Sollinger, HW .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :996-1001
[2]   Humoral theory of transplantation: Mechanism, prevention, and treatment [J].
Cai, J ;
Terasaki, PI .
HUMAN IMMUNOLOGY, 2005, 66 (04) :334-342
[3]  
COOK DJ, 1987, CLIN TRANSPLANT, V1, P253
[4]   In vitro accommodation of immortalized porcine endothelial cells - Resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies [J].
Dorling, A ;
Stocker, C ;
Tsao, T ;
Haskard, DO ;
Lechler, RI .
TRANSPLANTATION, 1996, 62 (08) :1127-1136
[5]   Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study [J].
Dudley, C ;
Pohanka, E ;
Riad, H ;
Dedochova, J ;
Wijngaard, P ;
Sutter, C ;
Silva, HT .
TRANSPLANTATION, 2005, 79 (04) :466-475
[6]   CAPILLARY DEPOSITION OF C4D COMPLEMENT FRAGMENT AND EARLY RENAL GRAFT LOSS [J].
FEUCHT, HE ;
SCHNEEBERGER, H ;
HILLEBRAND, G ;
BURKHARDT, K ;
WEISS, M ;
RIETHMULLER, G ;
LAND, W ;
ALBERT, E .
KIDNEY INTERNATIONAL, 1993, 43 (06) :1333-1338
[7]   Pre-transplant assessment of donor-reactive, HLA-specific antibodies in renal transplantation: Contraindication vs. risk [J].
Gebel, HM ;
Bray, RA ;
Nickerson, P .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (12) :1488-1500
[8]   HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction [J].
Girnita, AL ;
Duquesnoy, R ;
Yousem, SA ;
Iacono, AT ;
Corcoran, TE ;
Buzoianu, M ;
Johnson, B ;
Spichty, KJ ;
Dauber, JH ;
Burckart, G ;
Griffith, BP ;
McCurry, KR ;
Zeevi, A .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (01) :131-138
[9]   Acute vascular rejection of xenografts: Roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity [J].
Gollackner, B ;
Goh, SK ;
Qawi, I ;
Buhler, L ;
Knosalla, C ;
Daniel, S ;
Kaczmarek, E ;
Awwad, M ;
Cooper, DKC ;
Robson, SC .
TRANSPLANTATION, 2004, 77 (11) :1735-1741
[10]  
Iwaki Y., 1987, CLIN TRANSPLANT, V1, P125